Back to search
FDAFDA · Food and drugs·Recall number D-0940-2022

NB-343 Papaverine 30 mg/mL Phentolamine 3 mg/mL PGE 30 mcg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0010-10.

Published June 1, 2022 · Recall initiated: May 9, 2022

Summary

FDA records drug Class II recall D-0940-2022, published June 1, 2022 and initiated May 9, 2022. Recalling firm: Olympia Compounding Pharmacy dba Olympia Pharmacy; Status: Completed; Reported quantity: 606 vials; Lot: Lot: L24C08 BUD: 12/8/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Olympia Compounding Pharmacy dba Olympia Pharmacy
Distributor
Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands
Lot
Lot: L24C08 BUD: 12/8/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was NB-343 Papaverine 30 mg/mL Phentolamine 3 mg/mL PGE 30 mcg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0010-10. recalled?

Yes. FDA published recall D-0940-2022 on June 1, 2022. Reported hazard: Lack of assurance of sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Letter